Study in HFpEF Patients to Compare the Effect of AZD9977 and Spironolactone on Serum Potassium
A Phase I, Open Label, Randomized, Parallel Group, Multicentre Study to Compare the Effect of AZD9977 and Spironolactone on Serum Potassium [sK+] During 28 Days in Patients With HFmrEF or HFpEF and eGFR in the Range of ≥40 and ≤70 mL/Min/1.73m2.
Sponsor: AstraZeneca
Terminated
Attendance at study sites carries risk of COVID-19 infection. Non-attendance at planned study site visits has unacceptable study related patient safety risk.
This PHASE1 trial investigates Heart Failure and is currently terminated or withdrawn. AstraZeneca leads this study, which shows 25 recorded versions since 2018 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
25 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE1
-
Sep 2024 — Sep 2025 [monthly]
Terminated PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE1
-
Dec 2021 — Jul 2024 [monthly]
Terminated PHASE1
-
Jan 2021 — Dec 2021 [monthly]
Terminated PHASE1
▶ Show 20 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Terminated PHASE1
-
Jun 2020 — Nov 2020 [monthly]
Terminated PHASE1
Status: Active Not Recruiting → Terminated
-
May 2020 — Jun 2020 [monthly]
Active Not Recruiting PHASE1
Status: Recruiting → Active Not Recruiting
-
Apr 2020 — May 2020 [monthly]
Recruiting PHASE1
-
Feb 2020 — Apr 2020 [monthly]
Recruiting PHASE1
-
Jan 2020 — Feb 2020 [monthly]
Recruiting PHASE1
-
Dec 2019 — Jan 2020 [monthly]
Recruiting PHASE1
-
Nov 2019 — Dec 2019 [monthly]
Recruiting PHASE1
-
Oct 2019 — Nov 2019 [monthly]
Recruiting PHASE1
-
Sep 2019 — Oct 2019 [monthly]
Recruiting PHASE1
-
Aug 2019 — Sep 2019 [monthly]
Recruiting PHASE1
-
Jul 2019 — Aug 2019 [monthly]
Recruiting PHASE1
-
Jun 2019 — Jul 2019 [monthly]
Recruiting PHASE1
-
May 2019 — Jun 2019 [monthly]
Recruiting PHASE1
-
Mar 2019 — May 2019 [monthly]
Recruiting PHASE1
-
Feb 2019 — Mar 2019 [monthly]
Recruiting PHASE1
-
Jan 2019 — Feb 2019 [monthly]
Recruiting PHASE1
-
Dec 2018 — Jan 2019 [monthly]
Recruiting PHASE1
Status: Not Yet Recruiting → Recruiting
-
Nov 2018 — Dec 2018 [monthly]
Not Yet Recruiting PHASE1
-
Oct 2018 — Nov 2018 [monthly]
Not Yet Recruiting PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- AstraZeneca
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Brandýs nad Labem, Czechia , Hull, United Kingdom , Jaroměř, Czechia , Katowice, Poland , Krakow, Poland , Legnica, Poland , Leicester, United Kingdom , Louny, Czechia , Pardubice, Czechia , Plovdiv, Bulgaria and 6 more locations